Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).
REVOLUTION Medicines
19 followers
Freenome
10 followers
Halozyme Therapeutics
10 followers
BillionToOne
8 followers
Biocytogen
5 followers
Sage Bionetworks
5 followers
Pendulum
4 followers
Precigen
3 followers
Fractyl
3 followers
Prelude Therapeutics
3 followers
Viridian Therapeutics
2 followers
Relay Therapeutics
2 followers